vTv Therapeutics (VTVT) Net Margin (2014 - 2026)
vTv Therapeutics (VTVT) reported Net Margin of 65.51% for Q1 2026, up 100.31% sequentially from 21376.47% in Q4 2024.
vTv Therapeutics (VTVT) Net Margin (2014 - 2026) Analysis & Trends
vTv Therapeutics (VTVT) has 11 years of Net Margin data on file, last reported at 65.51% in Q1 2026.
- For the quarter ending Q1 2026, Net Margin changed N/A year-over-year to 65.51%; the trailing twelve-month figure through Mar 2026 stood at 6.11% (up 10994141.0% YoY), and the FY2024 full-year result was 1815.34%, changed N/A from the prior year.
- Net Margin advanced to 65.51% in Q1 2026, from 21376.47% in the prior quarter.
- In the past five years, Net Margin ranged from a high of 65.51% in Q1 2026 to a low of 52722.22% in Q4 2022.
- A 3-year average of 18313.52% and a median of 10931.49% in 2024 frame the typical range for Net Margin.
- Peak annual rise in Net Margin reached 2562222 bps in 2022, while the deepest fall reached 2825556 bps in 2022.
- Tracing VTVT's Net Margin over 3 years: stood at 52722.22% in 2022, then jumped by 59 bps to 21376.47% in 2024, then soared by 100 bps to 65.51% in 2026.
- Business Quant data shows VTVT's Net Margin at 65.51% in Q1 2026, 21376.47% in Q4 2024, and 486.5% in Q1 2024.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - | - |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn | 15.02% |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn | 34.53% |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn | 20.17% |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn | 30.33% |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - | - |
| 10 | vTv Therapeutics | 19.21 Mn | 19.21 Mn | - | 65.51% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 65.51% |
| Dec 31, 2024 | -21,376.47% |
| Mar 31, 2024 | -486.50% |
| Dec 31, 2022 | -52,722.22% |
| Jun 30, 2022 | -35,011.11% |
| Mar 31, 2022 | -350.35% |
| Dec 31, 2021 | -78,344.44% |
| Sep 30, 2021 | -36.23% |
| Jun 30, 2021 | -6,755.56% |
| Mar 31, 2021 | -602.03% |
| Dec 31, 2020 | 25.11% |
| Sep 30, 2020 | -32,185.71% |
| Mar 31, 2020 | -89,562.50% |
| Dec 31, 2019 | -98,314.29% |
| Sep 30, 2019 | -74,500.00% |
| Jun 30, 2019 | -279.76% |
| Mar 31, 2019 | -432.36% |
| Dec 31, 2018 | -51.48% |
| Sep 30, 2018 | -58.10% |
| Jun 30, 2018 | -388.03% |